6 Best Performing Drug Stocks of September   by Zacks on Oct 03, 2016
Company News for September 15, 2016   by Zacks on Sep 15, 2016

SRPT Industry Peers

Company Price Change (%)
Blueprint Medicines (BPMC)45.120.88 (1.91%)
Halozyme Therapeutics (HALO)13.290.05 (0.38%)
Aviragen Therapeutics (AVIR)0.60 (0%)
Biocryst Pharma (BCRX)6.510.1 (1.51%)
Gilead Sciences (GILD)65.930.57 (0.86%)
Ptc Therapeutics (PTCT)11.370.12 (1.07%)
Vertex Pharma (VRTX)116.70.56 (0.48%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
AKARI THERAPTC (AKTX)20.54.13 (25.23%)
Cytokinetics (CYTK)14.250.7 (5.17%)
Cascade Corp (CASC)4.10.18 (4.59%)
Bio-Rad Labs (BIO.B)2088.2 (4.1%)
Pluristem Therapeutics (PSTI)1.410.04 (2.92%)
Kindred Biosciences (KIN)7.150.2 (2.88%)
Inovio Pharma (INO)6.270.14 (2.28%)
Top gainers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Apr 22, 2017
CompanyPriceChange (%)
MannKind (MNKD)0.9250.15 (14.02%)
Immunomedics (IMMU)5.20.78 (13.04%)
Applied Genetic Technologies (AGTC)5.5750.63 (10.16%)
Mirati Therapeutics (MRTX)4.250.35 (7.61%)
Curis (CRIS)2.530.14 (5.24%)
Sangamo BioSciences (SGMO)4.050.2 (4.71%)
ZIOPHARM Oncology (ZIOP)6.790.31 (4.37%)
Top losers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Apr 22, 2017